BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19929743)

  • 1. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.
    Bradley WG
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():118-23. PubMed ID: 19929743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.
    Cox PA; Richer R; Metcalf JS; Banack SA; Codd GA; Bradley WG
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():109-17. PubMed ID: 19929742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Guam: cyanobacteria, BMAA and sporadic amyotrophic lateral sclerosis.
    Bradley WG; Cox PA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():5-6. PubMed ID: 19929725
    [No Abstract]   [Full Text] [Related]  

  • 5. Human exposure to cyanobacteria and BMAA.
    Brand LE
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():85-95. PubMed ID: 19929739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms.
    Caller TA; Doolin JW; Haney JF; Murby AJ; West KG; Farrar HE; Ball A; Harris BT; Stommel EW
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():101-8. PubMed ID: 19929741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid.
    Nunn PB
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():26-33. PubMed ID: 19929728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
    Banack SA; Metcalf JS; Bradley WG; Cox PA
    Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?
    Miller G
    Science; 2006 Jul; 313(5786):428-31. PubMed ID: 16873621
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyanobacteria and BMAA: possible linkage with avian vacuolar myelinopathy (AVM) in the south-eastern United States.
    Bidigare RR; Christensen SJ; Wilde SB; Banack SA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():71-3. PubMed ID: 19929736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
    Liu X; Rush T; Zapata J; Lobner D
    Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horses.
    Brenner SR
    Med Hypotheses; 2013 Jan; 80(1):103. PubMed ID: 23146671
    [No Abstract]   [Full Text] [Related]  

  • 14. BMAA--an unusual cyanobacterial neurotoxin.
    Vyas KJ; Weiss JH
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-N-methylaminoalanine (BMAA): metabolism and metabolic effects in model systems and in neural and other tissues of the rat in vitro.
    Nunn PB; Ponnusamy M
    Toxicon; 2009 Aug; 54(2):85-94. PubMed ID: 19285998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings from the symposium "Beyond Guam: New aspects of the Cyanobacteria/BMAA Hypothesis", 4 November 2008, UK.
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():5-126. PubMed ID: 20213893
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
    Li A; Tian Z; Li J; Yu R; Banack SA; Wang Z
    Toxicon; 2010 May; 55(5):947-53. PubMed ID: 19822166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease?
    Metcalf JS; Codd GA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Previous studies underestimate BMAA concentrations in cycad flour.
    Cheng R; Banack SA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():41-3. PubMed ID: 19929730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric and neurochemical alterations found in l-BMAA treated rats.
    de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Martínez A; Arahuetes RM
    Environ Toxicol Pharmacol; 2015 May; 39(3):1232-45. PubMed ID: 26002186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.